Shanghai Haihe Pharmaceutical Co., Ltd.;Shanghai Institute of Materia Medica, Chinese Academy of Sciences
发明人:
申请号：
EP18862819.2
公开号：
EP3702354A1
申请日:
2018.09.29
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The invention relates to a compound of formula (I):wherein variables are as defined in the specification. The compound is an inhibitor of an ERK kinase, e.g. ERK1 and/or ERK2 kinase. The invention also relates to the use of the compound and a method for preparing the compound, and a pharmaceutical composition containing the compound.
